Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Long-Term Investments (2016 - 2025)

Historic Long-Term Investments for Icu Medical (ICUI) over the last 10 years, with Q3 2025 value amounting to $134.1 million.

  • Icu Medical's Long-Term Investments changed N/A to $134.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $134.1 million, marking a year-over-year change of. This contributed to the annual value of $3.0 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Icu Medical reported Long-Term Investments of $134.1 million as of Q3 2025.
  • In the past 5 years, Icu Medical's Long-Term Investments ranged from a high of $134.1 million in Q3 2025 and a low of $516000.0 during Q4 2022
  • In the last 4 years, Icu Medical's Long-Term Investments had a median value of $4.6 million in 2021 and averaged $29.3 million.
  • As far as peak fluctuations go, Icu Medical's Long-Term Investments plummeted by 6439.03% in 2021, and later tumbled by 8883.12% in 2022.
  • Over the past 4 years, Icu Medical's Long-Term Investments (Quarter) stood at $4.6 million in 2021, then tumbled by 88.83% to $516000.0 in 2022, then skyrocketed by 488.76% to $3.0 million in 2024, then surged by 4313.63% to $134.1 million in 2025.
  • Its last three reported values are $134.1 million in Q3 2025, $131.6 million for Q2 2025, and $3.0 million during Q4 2024.